Subscribe to RSS
DOI: 10.1055/s-2008-1078177
Biginelli-Atwal Reactions of (+)-Pulegone: An Entry into Chiral Hexahydroquinazolin-2-one Derivatives
Publication History
Publication Date:
10 September 2008 (online)

Abstract
Biginelli-Atwal condensations of (+)-pulegone with (thio)ureas and guanidine afford hexahydroquinazoline-2(1H)-ones (-thiones) and/or 2-amino-1,3-thiazines with selectivities that depend on both the (thio)ureas and the experimental conditions. Carboannelation of these heterocyclic adducts with diethyl ethoxymethylenemalonate leads to uncommon pyrimidoquinazoline and pyrimidobenzothiazine systems.
Key words
pulegone - Biginelli-Atwal reactions - quinazolinone - carboannelation - pyrimidoquinazoline - pyrimidobenzothiazine
-
1a
Biginelli P. Ber. Dtsch. Chem. Ges. 1891, 24: 1317 -
1b
Biginelli P. Gazz. Chim. Ital. 1893, 23: 360 -
1c
Folkers K.Harwood HJ.Johnson TB. J. Am. Chem. Soc. 1932, 54: 3751 -
1d
Kappe CO. J. Org. Chem. 1997, 62: 7201 - For comprehensive reviews on Biginelli reaction, see:
-
2a
Kappe CO. Tetrahedron 1993, 49: 6937 -
2b
Kappe CO. Acc. Chem. Res. 2000, 33: 879 -
2c
Kappe CO.Stadler A. Org. React. 2004, 63: 1 -
2d
Simon C.Constantieux T.Rodriguez J. Eur. J. Org. Chem. 2004, 4957 -
2e
Kappe CO. Multicomponent ReactionsZhu J.Bienaymé H. Wiley-VCH; Weinheim: 2005. p.95-120 -
3a
Janis RA.Silver PJ.Triggle DJ. Adv. Drug Res. 1987, 16: 309 -
3b
Bossert F.Vater W. Med. Res. Rev. 1989, 9: 291 - 4 For a review about biologically active
DHPM, see:
Kappe CO. Eur. J. Med. Chem. 2000, 35: 1043 - 5
Hurst EW.Hull R. J. Med. Chem. Pharm. 1961, 3: 215 - 6
Kato T. inventors; JP 59190974. ; Chem. Abstr. 1985, 102, 132067m - 7
Bruce MA,Poindexter GS, andJohnson G. inventors; WO 9833791. ; Chem. Abstr. 1998, 129, 148989g -
8a
Kappe CO. Molecules 1998, 3: 1 -
8b
Kappe CO. QSAR Comb. Sci. 2003, 22: 630 - 9
Barrow JC.Nantermet PG.Selnick HG.Glass KL.Rittle KE.Freidinger RM.Ransom RW.O’Malley SS.Eppert P.Nagarathnam D.Forray C. J. Med. Chem. 2000, 43: 2703 -
10a
Hassani Z.Islami MR.Kalantari M. Bioorg. Med. Chem. Lett. 2006, 16: 4479 -
10b
Lin H.Zhaoa Q.Xua B.Wanga X. J. Mol. Catal. A: Chem. 2007, 268: 221 - 11
Yarim M.Saraç S.Kiliç FS.Erol K. Il Farmaco 2003, 58: 17 - 12
Kidwai M.Saxena S.Khan MKR.Thukral SS. Eur. J. Med. Chem. 2005, 816 -
13a
Mayer TU.Kapoor TM.Haggarty SJ.King RW.Schreiber SL.Mitchison TJ. Science 1999, 286: 971 -
13b
Cheng J.Quidong Y.Zhiyu L.Quinglong G. Exp. Opin. Ther. Pat. 2006, 16: 1517 -
14a
Gartner M.Sunder-Plassmann N.Seiler J.Utz M.Vernos I.Surrey T.Giannis A. ChemBioChem 2005, 6: 1173 -
14b
Sarli V.Giannis A. ChemMedChem 2006, 1: 293 -
14c
Müller C.Gross D.Sarli V.Gartner M.Giannis A.Bernhardt G.Buschauer A. Cancer Chemother. Pharmacol. 2007, 59: 157 -
15a
Patil AD.Vasant Kumar N.Kokke WC.Bean MF.Freyer AJ.De Brosse C.Mai S.Truneh A.Faulkner DJ.Carte B.Breen AL.Hertzberg RP.Johnson RK.Westley JW.Potts BCM. J. Org. Chem. 1995, 60: 1182 -
15b
Snider BB.Shi Z. J. Org. Chem. 1993, 58: 3828 -
15c
Overman LE.Rabinowitz MH.Renhowe PA. J. Am. Chem. Soc. 1995, 117: 2657 -
16a
Chen W.-Y.Quin S.-D.Jin J.-R. Synth. Commun. 2007, 37: 47 -
16b
Debache A.Boumoud B.Amimour M.Belfaitah A.Rhouati S.Carboni B. Tetrahedron Lett. 2006, 47: 5697 -
16c
van Lier JE.Ahmed N. Tetrahedron Lett. 2007, 48: 5407 ; and references cited therein -
17a
Li J.-T.Han J.-F.Yang J.-H.Li T.-S. Ultrason. Sonochem. 2003, 10: 119 -
18a
Desai B.Dallinger D.Kappe CO. Tetrahedron 2006, 62: 4651 -
18b
Xue S.Shen YC.Li YL.Shen XM.Guo QX. Chin. J. Chem. 2002, 20: 385 -
19a
Peng JJ.Deng YQ. Tetrahedron Lett. 2001, 42: 5917 -
19b
Legeay J.-C.Vanden Eynde JJ.Bazureau JP. Tetrahedron 2005, 61: 12386 -
20a
Kappe CO.Uray G.Roschger P.Lindmer W.Kratky C.Keller W. Tetrahedron 1992, 48: 5473 -
20b
Muñoz-Muñiz O.Juaristi E. Arkivoc 2003, (xi): 16 -
20c
Lou S.Taoka BM.Ting A.Schaus SE. J. Am. Chem. Soc. 2005, 127: 11256 -
20d
Huang Y.Yang F.Zhu C. J. Am. Chem. Soc. 2005, 127: 16386 -
20e
Chen X.-H.Xu X.-Y.Liu H.Cun L.-F.Gong L.-Z. J. Am. Chem. Soc. 2005, 128: 14802 - For reaction of guanidine, see:
-
21a
Traube W.Schwarz R. Ber. Dtsch. Chem. Ges. 1899, 32: 3163 -
21b
Wendelin W.Harler A. Monatsh. Chem. 1974, 105: 563 - For reaction of urea, see:
-
22a
Harvey MT. inventors; US 2592 565. ; Chem. Abstr. 1953, 47, 601d -
22b
Hatt HH.Triffet ACK. J. Chem. Soc., Chem. Commun. 1965, 439 -
22c
Zigeuner G.Fuch E.Galatik W. Monatsh. Chem. 1966, 97: 43 -
22d
Hatt HH.Lichtenwalter GD.Riesser GH. Aust. J. Chem. 1970, 23: 561 -
22e
Butler AR.Hussain I. J. Chem. Soc., Perkin Trans. 2 1980, 232 - Reactions under neutral conditions:
-
23a
Wendelin W.Harler A. Monatsh. Chem. 1975, 106: 1479 -
23b
Wendelin W.Harler A.Fuchsgruber A. Monatsh. Chem. 1976, 107: 141 - Reactions under acidic conditions:
-
24a
Zigeuner G.Eisenreich V.Weichsel H.Adam W. Monatsh. Chem. 1970, 101: 1731 -
24b
Zigeuner G.Gübitz G.Eisenreich V. Monatsh. Chem. 1970, 101: 1686 - Reactions under basic conditions:
-
25a
Zimmerman R.Brähler B.Hotze H. Angew. Chem. 1960, 72: 78 -
25b
Zigeuner G.Strallhofer T.Wede F.Lintschinger W. Monatsh. Chem. 1975, 106: 1469 -
25c
El-Rayyes NR. J. Heterocycl. Chem. 1982, 19: 415 -
25d
El-Rayyes NR.Ramadan HM. J. Heterocycl. Chem. 1987, 24: 589 -
25e
Lorand T.Deli J.Szabo D.Foldesi A.Zschunke A. Pharmazie 1985, 40: 536 -
25f
Joshi KC.Dandia A.Sanan S. J. Heterocycl. Chem. 1989, 26: 1397 -
25g
Marzinzick AL.Felder ER. J. Org. Chem. 1998, 63: 723 -
25h
Bertozzi F.Gundersen BV.Gustafsson M.Olsson R. Org. Lett. 2003, 5: 1551 -
25i
Klimova EI.Klimova TB.Hernández SO.Martinez MG. Heterocycles 2003, 60: 2231 - 26 Only one result from pulegone was
reported. Its reaction with free guanidine in refluxing benzene
gave the corresponding 2-aminohexahydroquinazoline 17a in
74% yield. See:
Weis AL.Frolow F.Vishkautsan R. J. Heterocycl. Chem. 1986, 23: 705 -
27a
O’Reilly BC.Atwal KS. Heterocycles 1987, 26: 1185 -
27b
Atwal KS.O’Reilly BC.Gougoutas JZ. Heterocycles 1987, 26: 1189 -
27c
Atwal KS.Rovnyak GC.O’Reilly BC.Atwal KS. J. Org. Chem. 1989, 54: 5898 - For previous reports on similar access to 2-amino-1,3-thiazines, see:
-
29a
Chase BH. J. Chem. Soc. 1955, 4443 -
29b
Zimmerman R. Angew. Chem. 1963, 75: 1025 - For previous work on the use of 2-aminopyrimidine derivatives for the construction of heterocycles, see:
-
31a
Greenhill JV.Jamil Ismail M. J. Chem. Soc., Perkin Trans. 2 1985, 1255 -
31b
Kaddachi MT.Ben Amor M.Zouari S.Cossy J.Kahn P. J. Soc. Chim. Tunisie 1999, 6: 537 -
31c
Vanden Eynde JJ.Hecq N.Kateava O.Kappe CO. Tetrahedron 2001, 57: 1785 - For the synthesis of heterocycles from dihydropyrimidine-2 (1H)-thiones, see:
-
32a
Kappe CO.Roschger P. J. Heterocycl. Chem. 1989, 26: 55 -
32b
Bozing D.Sohar P.Gigler G.Kovacs G. Eur. J. Med. Chem. 1996, 31: 663 -
33a
Chicharro JL.Prados P.de Mendoza J. J. Chem. Soc., Chem. Commun. 1994, 1193 -
33b
Jimenez JM,Patel S,Kay D,Knegtel R, andPhilps O. inventors; US 46664. ; Chem. Abstr. 2005, 143, 326386 -
33c
Grover RK.Kesarwani AP.Srivastava GK.Kundu B.Roy R. Tetrahedron 2005, 61: 5011
References and Notes
Typical Experimental
Procedure (Table 1, entry 4) - Synthesis of (7
R
)-3,4,5,6,7,8-Hexahydro-4,4,7-trimethyl-quinazolin-2
(1
H
)-one (14a)
To a solution of urea 3a (1.2 g, 20 mmol) in EtOH (20 mL), was
added 11 N HCl (0.9 mL, 10 mmol) and (+)-pulegone (13, 1.52 g, 10 mmol). The mixture was stirred
at reflux for 14 h. Most of the EtOH was evaporated, so that a solid precipitated
on cooling. The solid was filtered and washed with H2O.
Recrystallization from acetone gave 14a (2.33
g, 78%) as a white solid; mp 161-163 ˚C.
TLC (SiO2, EtOAc): R
f
= 0.18.
IR (KBr, film): 3223, 2969, 2922, 1701, 1574, 1494, 1437, 1359,
1189, 1168, 740 cm-¹. [α]D
²0 +61.1
(c 1.0; CH2Cl2). ¹H
NMR (300 MHz, CDCl3): δ = 7.71 (s,
1 H,
N1-H), 5.76 (s, 1 H, N3-H), 1.95-2.00 (m,
3 H, H-5, H-7,
H-8), 1.60-1.75 (m, 3 H, H-5′,
H-6, H-8′), 1.19 [s, 6 H, C(CH
3)2],
1.05-1.30 (m, 1 H, H-6′), 0.90 [d,
³
J = 5.3
Hz, 3 H, CH(CH
3)]. ¹³C
NMR (75.5 MHz, CDCl3): δ = 155.9 (C=O),
126.8 (C-8a), 109.5 (C-4a), 55.3 (C-4), 34.3 (C-8), 31.4 (C-5),
29.2 and 29.0 [C(CH3)2],
28.7 (C-7), 22.5 (C-6), 21.7 [CH(CH3)].
Anal. Calcd for C11H18N2O: C, 66.97;
H, 9.34; O, 23.69. Found: C, 66.88; H, 9.47; O, 23.65.
(7R)-3,4,4a,5,6,7-Hexahydro-1,4,4,7-tetramethylquin-azolin-2
(1H)-one(18)
was obtained as a single diastereomer to which the cis-18 structure was tentatively assigned. Indeed,
the ¹H NMR and ¹³C
NMR spectra [δ (¹H): singlets at
0.97 and 1.13 ppm; δ (¹³C):
23.2 and 27.2 ppm] of this diastereomer show two very differentiated gem-methyl groups, which is in consideration
of a CH3/H (on C-7 and
C-4a carbon
atoms) cis-relationship after comparison
of the molecular models of both cis-
18 and trans-18 structures. This cis-relationship
is also predicted according to the plausible mechanistic pathways
for the formation of hexahydroquinazolinones 14b and 18: i) acid-catalyzed 1,4-addition of the
less-hindered nitrogen atom of methylurea 3b to
the conjugated enone system giving a cis-diequatorial cyclohexanone
intermediate; ii) intramolecular condensation of the NHMe nitrogen
on the carbonyl group; iii) β-elimination of a proton,
H-4a or H-8 proton, giving rise to hexahydroquinazolinone 14b or cis-18, respectively.